These results collectively suggest that MLK3 promoter favors recruitment of corepressors instead of coactivators to downregulate MLK3 gene expression and finally leading to suppression of apoptotic function of MLK3 in ER+ breast cancer. This evidence concerns the gene MAP3K11 and breast cancer.